D. Brantley-Sieders

发表

Host deficiency in ephrin-A 1 inhibits breast cancer metastasis [ version 2 ; peer review : 3 approved ]

Dana M. Brantley-Sieders, E. Shiuan, Ashwin Inala, 2021 .

Host deficiency in ephrin-A1 inhibits breast cancer metastasis.

Dana M. Brantley-Sieders, E. Shiuan, Ashwin Inala, 2020, F1000Research.

Host deficiency in ephrin-A1 inhibits breast cancer metastasis

Dana M. Brantley-Sieders, E. Shiuan, Ashwin Inala, 2020, F1000Research.

Eph receptor tyrosine kinases in tumor and tumor microenvironment.

D. Brantley-Sieders, Sonja Schmidt, M. Parker, 2004, Current pharmaceutical design.

Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.

Dana M. Brantley-Sieders, J. Balko, Andrew Williams, 2014, The Journal of clinical investigation.

Phosphorylation of PLCγ1 by EphA2 Receptor Tyrosine Kinase Promotes Tumor Growth in Lung Cancer

Dana M. Brantley-Sieders, F. Cheng, Yuan Hou, 2020, Molecular Cancer Research.

Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis

W. Muller, D. Brantley-Sieders, D. Sarbassov, 2017, Breast Cancer Research.

Identification and Functional Analysis of Phosphorylated Tyrosine Residues within EphA 2 Receptor Tyrosine Kinase *

Dana M. Brantley-Sieders, Jin Chen, D. Brantley-Sieders, 2008 .

Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site.

Dana M. Brantley-Sieders, D. Brantley-Sieders, J. Cates, 2009, Cancer research.

EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease

Shan Wang, D. Brantley-Sieders, Rachelle W Johnson, 2020, JBMR plus.

Expression of the TAL1/SCL transcription factor in physiological and pathological vascular processes

Dana M. Brantley-Sieders, Y. Shi, D. Brantley-Sieders, 2006, The Journal of pathology.

Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.

M. V. Estrada, W. Muller, D. Brantley-Sieders, 2016, Cancer Research.

Tumor-specific EphA2 receptor tyrosine kinase inhibits anti-tumor immunity by recruiting suppressive myeloid populations in NSCLC

Dana M. Brantley-Sieders, E. Shiuan, Shan Wang, 2020, bioRxiv.

Determination of the CD148-Interacting Region in Thrombospondin-1

Dana M. Brantley-Sieders, Jin Chen, D. Brantley-Sieders, 2016, PloS one.

Eph receptors in breast cancer: roles in tumor promotion and tumor suppression

Dana M. Brantley-Sieders, D. Brantley-Sieders, Junya Chen, 2008, Breast Cancer Research.

Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis

W. Muller, D. Brantley-Sieders, D. Sarbassov, 2017, Breast Cancer Research.

Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity

Dana M. Brantley-Sieders, E. Shiuan, Shan Wang, 2020, JCI insight.

Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers

J. Balko, W. Song, J. Chen, 2017, Oncogene.

Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy.

Lu Xie, Carlos Arteaga, Dana M. Brantley-Sieders, 2010, Cancer research.

VAMP-Associated Protein B (VAPB) Promotes Breast Tumor Growth by Modulation of Akt Activity

Dana M. Brantley-Sieders, S. Lev, Y. Shyr, 2012, PloS one.

JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.

Dana M. Brantley-Sieders, Wenqiang Song, D. Brantley-Sieders, 2014, Cancer research.

Small Cell Lung Cancer − like Properties in Non − Proliferation , Motility , and Cancer Stem Cell JNK Signaling Mediates EPHA 2-Dependent Tumor Cell

Dana M. Brantley-Sieders, Wenqiang Song, Jin Chen, 2014 .

Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient Endothelium

Shan Wang, Wenqiang Song, V. Youngblood, 2014, Molecular Cancer Research.

Elevated Slit 2 Activity Impairs VEGF-induced Angiogenesis and Tumor Neovascularization in EphA 2-deficient Endothelium

Shan Wang, Wenqiang Song, V. Youngblood, 2014 .

Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium.

Jane Y. Wu, Deyu Li, Y. Shyr, 2011, Cancer research.

Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1

Dana M. Brantley-Sieders, M. Sanders, H. Moses, 2003, Molecular and Cellular Biology.

Cooperative Signaling between Slit2 and Ephrin-A1 Regulates a Balance between Angiogenesis and Angiostasis

Dana M. Brantley-Sieders, Jane Y. Wu, C. Lindsley, 2010, Molecular and Cellular Biology.

Host Deficiency in Vav2/3 Guanine Nucleotide Exchange Factors Impairs Tumor Growth, Survival, and Angiogenesis In vivo

Jin Chen, D. Brantley-Sieders, G. Zhuang, 2009, Molecular Cancer Research.

Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing

Craig L Duvall, Linus Lee, Dana M. Brantley-Sieders, 2017, Proceedings of the National Academy of Sciences.

The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ

Dana M. Brantley-Sieders, E. Shiuan, Shan Wang, 2017, Science Signaling.

Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.

Dana M. Brantley-Sieders, D. Brantley-Sieders, Junya Chen, 2006, Cancer research.

Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer*

Michael L. Gatza, Alissa M. Weaver, C. Perou, 2015, Molecular & Cellular Proteomics.

Award Number: W81XWH-10-1-0256 TITLE: Role of VAPB-MSP, a Novel EphA2 RTK Antagonist in Breast Cancer

S. Lev, Y. Shyr, Wenqiang Song, 2013 .

Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer

Kalin L. Wilson, Dana M. Brantley-Sieders, E. Shiuan, 2021, Oncogene.

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Dana M. Brantley-Sieders, D. Jackson, E. Bruckheimer, 2008, The Journal of clinical investigation.

Eph/Ephrin Profiling in Human Breast Cancer Reveals Significant Associations between Expression Level and Clinical Outcome

Dana M. Brantley-Sieders, Y. Shyr, Jin Chen, 2011, PloS one.

Local Breast Cancer Spatial Patterning: A Tool for Community Health Resource Allocation to Address Local Disparities in Breast Cancer Mortality

Dana M. Brantley-Sieders, S. Deming-Halverson, Y. Shyr, 2012, PloS one.

The receptor tyrosine kinase EphA 2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB 2 signaling

Dana M. Brantley-Sieders, D. Jackson, E. Bruckheimer, 2007 .

LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer)

C. Andl, W. Yarbrough, V. Youngblood, 2016, PloS one.

The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells

Dana M. Brantley-Sieders, Jin Chen, D. Brantley-Sieders, 2015, Breast Cancer Research and Treatment.

mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis

Dana M. Brantley-Sieders, Shan Wang, D. Brantley-Sieders, 2015, PLoS genetics.

Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study

Dana M. Brantley-Sieders, H. Hamm, J. Pulley, 2020, Molecular Cancer Therapeutics.

Molecular and Cellular Pathobiology Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA 2 Repression of Slit 2 Tumor Suppressor Function in Endothelium

Jane Y. Wu, Deyu Li, Y. Shyr, 2011 .

Essential Role of Vav Family Guanine Nucleotide Exchange Factors in EphA Receptor-Mediated Angiogenesis

Dana M. Brantley-Sieders, W. Swat, D. Brantley-Sieders, 2006, Molecular and Cellular Biology.

Eph Receptor Tyrosine Kinases in Angiogenesis: From Development to Disease

Dana M. Brantley-Sieders, D. Brantley-Sieders, Junya Chen, 2004, Angiogenesis.

Abstract B048: The role of mTORC2 in mammary morphogenesis and HER2-mediated tumorigenesis

D. Brantley-Sieders, R. Cook, V. Sanchez, 2013 .

Identification and Functional Analysis of Phosphorylated Tyrosine Residues within EphA2 Receptor Tyrosine Kinase*

Dana M. Brantley-Sieders, Jin Chen, D. Brantley-Sieders, 2008, Journal of Biological Chemistry.

Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.

Dana M. Brantley-Sieders, D. Brantley-Sieders, 2012, Seminars in cell & developmental biology.

Regulation of Endothelial Cell Proliferation and Vascular Assembly through Distinct mTORC2 Signaling Pathways

Dana M. Brantley-Sieders, Shan Wang, Wenqiang Song, 2015, Molecular and Cellular Biology.

Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinase.

Dana M. Brantley-Sieders, Jin Chen, D. Brantley-Sieders, 2009, Molecular biology of the cell.

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

Dana M. Brantley-Sieders, C. Duvall, Shan Wang, 2018, Cancer research.

Impaired tumor microenvironment in EphA2‐deficient mice inhibits tumor angiogenesis and metastatic progression

Dana M. Brantley-Sieders, Y. Shyr, D. Brantley-Sieders, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation

Dana M. Brantley-Sieders, A. Pozzi, Jin Chen, 2004, Journal of Cell Science.

A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis

Dana M. Brantley-Sieders, A. Reith, Jin Chen, 2005, Oncogene.

Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC.

Dana M. Brantley-Sieders, N. Gray, D. Colvin, 2014, The Journal of clinical investigation.

Effects of cancer-associated EPHA3 mutations on lung cancer.

Yu Shyr, Mark Boothby, Yan Guo, 2012, Journal of the National Cancer Institute.

Eph Receptors and Ephrins: Role in Vascular Development and Tumor Angiogenesis

Dana M. Brantley-Sieders, Jin Chen, D. Brantley-Sieders, 2008 .

Inhibition of retinal neovascularization by soluble EphA2 receptor.

Dana M. Brantley-Sieders, Jin Chen, D. Brantley-Sieders, 2006, Experimental eye research.

Receptor-Mediated Angiogenesis Nucleotide Exchange Factors in EphA Essential Role of Vav Family Guanine

Dana M. Brantley-Sieders, W. Swat, Jin Chen, 2014 .

The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.

S. Stirdivant, V. Youngblood, D. Brantley-Sieders, 2016, Cancer research.

The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.

Dana M. Brantley-Sieders, S. Stirdivant, V. Youngblood, 2016, Cancer research.

Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium.

Dana M. Brantley-Sieders, Jane Y. Wu, Deyu Li, 2011, Cancer research.